327 related articles for article (PubMed ID: 8568162)
1. [Efficacy and tolerability of 2 presentations of eyedrops combining carteolol 2% and pilocarpine 2% in primary open-angle glaucoma and simple ocular hypertension].
Sirbat D; Charlin JF; Cohn H; Dascotte JC; George JL; Lesure P; Massin M; Massin G; Maurin JF; Renard JP
J Fr Ophtalmol; 1995; 18(10):589-96. PubMed ID: 8568162
[TBL] [Abstract][Full Text] [Related]
2. [Efficacy and safety of long-acting carteolol 1% once daily. A double-masked, randomized study].
Trinquand C; Romanet JP; Nordmann JP; Allaire C;
J Fr Ophtalmol; 2003 Feb; 26(2):131-6. PubMed ID: 12660585
[TBL] [Abstract][Full Text] [Related]
3. Comparison of two fixed beta-blocker-pilocarpine combinations. The Carteolol-Pilocarpine Study Group.
Bron AM; Garcher CP; Sirbat D; Allaire CM; Lablache-Combier MJ; Trinquand CJ
Eur J Ophthalmol; 1997; 7(4):351-6. PubMed ID: 9457458
[TBL] [Abstract][Full Text] [Related]
4. Ocular hypotensive efficacy and safety of a combined formulation of betaxolol and pilocarpine.
Robin AL
Trans Am Ophthalmol Soc; 1996; 94():89-101; discussion 101-3. PubMed ID: 8981691
[TBL] [Abstract][Full Text] [Related]
5. [Ocular hypotensive effect of 1% carteolol long-acting eye drops--a double-masked, randomized phase III study in ocular hypertension or primary open-angle glaucoma patients comparing long-acting carteolol eye drops vs. current product].
Yamamoto T;
Nippon Ganka Gakkai Zasshi; 2007 Jun; 111(6):463-72. PubMed ID: 17601060
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of latanoprost versus pilocarpine/timolol maleate fixed combination in patients with primary open-angle glaucoma or ocular hypertension.
Kałuzny J; Sobecki R; Czechowicz-Janicka K; Kecik D; Kałuzny BJ; Stewart JA; Stewart WC
Acta Ophthalmol; 2008 Dec; 86(8):860-5. PubMed ID: 18721251
[TBL] [Abstract][Full Text] [Related]
7. [Hypotensive action of 0.5% carteolol versus 0.1% timolol in patients with intraocular hypertension].
Allaire C; Trinquand C; Nordmann JP; Dascotte JC; George JL; Lesure P; Rouland JF; Khaitrine L; Sirbat D
J Fr Ophtalmol; 1995; 18(1):22-6. PubMed ID: 7738291
[TBL] [Abstract][Full Text] [Related]
8. [Primary open-angle glaucoma. Effects of an eyedrop combining timolol and pilocarpine on the ocular pressure].
Leroy C; Collignon-Brach J
J Fr Ophtalmol; 1990; 13(1-2):29-32. PubMed ID: 2212504
[TBL] [Abstract][Full Text] [Related]
9. A 6-week, double-masked, parallel-group study of the efficacy and safety of travoprost 0.004% compared with latanoprost 0:005%/timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension.
Franks WA; Renard JP; Cunliffe IA; Rojanapongpun P
Clin Ther; 2006 Mar; 28(3):332-9. PubMed ID: 16750448
[TBL] [Abstract][Full Text] [Related]
10. [Timolol 0.5%/dorzolamide 2% fixed combination versus timolol 0.5%/pilocarpine 2% fixed combination in primary open-angle glaucoma or ocular hypertensive patients].
Kałuzny JJ; Szaflik J; Czechowicz-Janicka K; Kałuzny J; Orzałkiewicz A; Zaleska-Zmijewska A; Krajewska M; Stewart JA; Leech JN; Stewart WC
Klin Oczna; 2004; 106(1-2 Suppl):241-2. PubMed ID: 15510513
[TBL] [Abstract][Full Text] [Related]
11. Intraocular pressure-lowering effects of latanoprost monotherapy versus latanoprost or pilocarpine in combination with timolol: a randomized, observer-masked multicenter study in patients with open-angle glaucoma. Italian Latanoprost Study Group.
Bucci MG
J Glaucoma; 1999 Feb; 8(1):24-30. PubMed ID: 10084271
[TBL] [Abstract][Full Text] [Related]
12. The dorzolamide/timolol combination versus timolol plus pilocarpine: patient preference and impact on daily life. United States Patient Preference Study Group. International Patient Preference Study Group.
Sverrisson T; Gross R; Pearson J; Rusk C; Adamsons I
J Glaucoma; 1999 Oct; 8(5):315-24. PubMed ID: 10529932
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular effects of topical carteolol hydrochloride and timolol maleate in patients with ocular hypertension and primary open-angle glaucoma. Night Study Group.
Netland PA; Weiss HS; Stewart WC; Cohen JS; Nussbaum LL
Am J Ophthalmol; 1997 Apr; 123(4):465-77. PubMed ID: 9124243
[TBL] [Abstract][Full Text] [Related]
14. The safety and efficacy of brinzolamide 1%/timolol 0.5% fixed combination versus dorzolamide 2%/timolol 0.5% in patients with open-angle glaucoma or ocular hypertension.
Manni G; Denis P; Chew P; Sharpe ED; Orengo-Nania S; Coote MA; Laganovska G; Volksone L; Zeyen T; Filatori I; James J; Aung T
J Glaucoma; 2009; 18(4):293-300. PubMed ID: 19365194
[TBL] [Abstract][Full Text] [Related]
15. A comparative evaluation of pilocarpine 1% and clonidine 0.125% versus timolol 0.5%.
Sihota R; Agarwal HC; Rajashekar YL
Indian J Ophthalmol; 1996 Jun; 44(2):87-9. PubMed ID: 8916595
[TBL] [Abstract][Full Text] [Related]
16. The safety and efficacy of travoprost 0.004%/timolol 0.5% fixed combination ophthalmic solution.
Barnebey HS; Orengo-Nania S; Flowers BE; Samples J; Mallick S; Landry TA; Bergamini MV
Am J Ophthalmol; 2005 Jul; 140(1):1-7. PubMed ID: 15990081
[TBL] [Abstract][Full Text] [Related]
17. Effects of carteolol and timolol on plasma lipid profiles in older women with ocular hypertension or primary open-angle glaucoma.
Stewart WC; Dubiner HB; Mundorf TK; Laibovitz RA; Sall KN; Katz LJ; Singh K; Shulman DG; Siegel LI; Hudgins AC; Nussbaum L; Apostolaros M
Am J Ophthalmol; 1999 Feb; 127(2):142-7. PubMed ID: 10030554
[TBL] [Abstract][Full Text] [Related]
18. Dorzolamide/timolol combination versus concomitant administration of brimonidine and timolol: six-month comparison of efficacy and tolerability.
Sall KN; Greff LJ; Johnson-Pratt LR; DeLucca PT; Polis AB; Kolodny AH; Fletcher CA; Cassel DA; Boyle DR; Skobieranda F
Ophthalmology; 2003 Mar; 110(3):615-24. PubMed ID: 12623832
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of a fixed combination of travoprost 0.004%/timolol 0.5% ophthalmic solution once daily for open-angle glaucoma or ocular hypertension.
Schuman JS; Katz GJ; Lewis RA; Henry JC; Mallick S; Wells DT; Sullivan EK; Landry TA; Bergamini MV; Robertson SM
Am J Ophthalmol; 2005 Aug; 140(2):242-50. PubMed ID: 16086946
[TBL] [Abstract][Full Text] [Related]
20. Meta-analysis of 24-hour intraocular pressure studies evaluating the efficacy of glaucoma medicines.
Stewart WC; Konstas AG; Nelson LA; Kruft B
Ophthalmology; 2008 Jul; 115(7):1117-1122.e1. PubMed ID: 18082886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
